Inventor
SHEFFLER DOUGLAS J
US10 patents
⚠️ This page may combine multiple inventors who share the name “SHEFFLER DOUGLAS J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LINDSLEY CRAIG W
5 patentsUS8497289B2Jul 30, 2013
3.1.0 bicyclic GlyT1 inhibitors and methods of making and using same
LINDSLEY CRAIG W3 citations61
US8436019B2May 7, 2013
Sulfonyl-piperidin-4-yl methylamine amide analogs as GlyT1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
LINDSLEY CRAIG W1 citations51
US8431700B2Apr 30, 2013
Alkylsulfonyl-2,3-dihydrospiro[indene-1,4′-piperidine] analogs as GlyT1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
LINDSLEY CRAIG W1 citations51
US8211933B2Jul 3, 2012
3.3.0 bicyclic GlyT1 inhibitors and methods of making and using same
LINDSLEY CRAIG W1 citations51
US8207155B2Jun 26, 2012
Sulfonyl-azetidin-3-yl-methylamine amide analogs as GlyTl inhibitors, methods for making same, and use of same in treating psychiatric disorders
LINDSLEY CRAIG W1 citations51
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
2 patentsUS10597367B2Mar 24, 2020
Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST3 citations68
US11447453B2Sep 20, 2022
Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST0 citations57
SANFORD BURNHAM MED RES INST
2 patentsUS9969726B2May 15, 2018
Metabotropic glutamate receptor negative allosteric modulators (NAMS) and uses thereof
SANFORD BURNHAM MED RES INST2 citations68
US10099993B2Oct 16, 2018
Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof
SANFORD BURNHAM MED RES INST0 citations47